Add like
Add dislike
Add to saved papers

Coronary sinus Reducer non-responders: insights and perspectives.

EuroIntervention 2018 Februrary 21
AIMS: Coronary sinus (CS) Reducer is currently indicated for the treatment of refractory angina in patients unsuitable for coronary revascularization. A 15-30% of non-responders is a constant across literature. Alternative coronary venous drainage systems may be an important factor in determining if patients "respond" to this intervention. We propose a simple method to indirectly assess the presence of these alternative drainage systems and predict responsiveness to Reducer implantation.

METHODS AND RESULTS: We measure the differential pressure between baseline right atrial pressure and CS systolic pressure during balloon occlusion of the CS. In the majority of patients, most of the left coronary artery venous return is drained by the CS. These patients show a high differential pressure due effective interference of the Reducer with coronary venous return. Narrowing of the CS effectively reduces venous return establishing its anti-ischemic effects, with the most expected benefit from Reducer implantation. Patients with developed accessory venous drainage systems will show low differential pressures due to preserved alternative coronary venous outflow. In these patients, Reducer results in an insufficient pressure gradient across the CS and the anti-ischemic effects and benefits might be minimal.

CONCLUSIONS: We suggest a simple and effective diagnostic peri-procedural method that may provide additional information in predicting responders to Reducer therapy. We also explore CS hemodynamics in the setting of Reducer implantation, trying to give insights on the pathophysiology and biologic effect of this novel treatment. This may help clinicians to better select patients to undergo implantation, avoiding useless procedures and risks.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app